demonstrated to be a Rickettsia-like organism. Results of subsequent studies were controversial because of suspected contamination of cultures. The species R. felis was formally validated by molecular criteria in 2001, and the reference strain was isolated in 2002 (4) . R. felis has been demonstrated to belong to the SFG (5) .
R. felis is distributed worldwide (online Technical Appendix, available from www.cdc.gov/EID/content/15/7/ 1126-Techapp.pdf), although it has not been found in the northern, coldest regions. The vectors described include fleas, ticks, and mites; however, the only currently recognized vector is the C. felis flea (6) . The reported hosts for these vectors are mainly cats, dogs, and rodents. R. felis is the only SFG species that is transmitted by fleas. Studies have confirmed that R. felis in C. felis flea populations is mostly maintained by transstadial and transovarial transmission (7) . Levels of R. felis infestation in C. felis fleas are variable, and the specific mechanisms of maintenance within each flea remain unknown. Prevalence is increased by fleas feeding on mammalian hosts infected with R. felis. Nevertheless, the precise relationship between the vector and the host remains unknown, and the mechanisms of rickettsial replication have not yet been examined (7).
We searched PubMed and found reports (case reports and seroprevalence studies) of 68 R. felis infections. Cases have been reported in the Americas, Asia, Tunisia, and Europe (online Technical Appendix). Such clinical cases rarely occur in warm countries, unlike the worldwide distribution of the bacteria, mentioned above. Reports of human infection with R. felis are rare, but the organism is frequently isolated from fleas.
We summarized the available clinical findings for 34 persons infected with R. felis: 32 had fever; 24, cutaneous rash (mostly maculopapular); 4, cutaneous eschar; 5, neurologic signs; 7, digestive symptoms; 3, cough without pneumonia; and 2, pneumonia. Clinical findings for R. felis are often confused with those found for patients with murine typhus or other febrile illnesses, and they appear to be more complex and more severe than initially thought.
R. felis infections can be diagnosed by serologic testing (1), molecular analysis, or a combination of each. Several molecular methods for detection of R. felis have focused on the presence of several genes, but real-time PCR assays are becoming increasingly useful (8) . Serologic profiles for R. felis infections differ; cross-reactions with SFG rickettsiae as well as with SFG rickettsiae and R. typhi have been observed, but a lack of cross-reactions has also been observed (9) . It has been noted (10) that when cross-reactions were observed between R. felis and both R. conorii and R. typhi, the infection was probably related to R. felis. When cross-reactions were observed between R. felis and only R. typhi, the causative agent was most probably of the typhus group.
R. felis infections occur globally and are linked to the worldwide distribution of vectors, but the occurrence is relatively rare when compared with the high frequency of R. felis infections related to flea infestation. Human infections remain poorly characterized and are apparently underappreciated, possibly because of the lack of specific signs and symptoms. Further characterization of the interactions between R. felis and fleas could elucidate the particular epidemiology and pathology of flea-borne spotted fever.
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